Ladenburg Thalmann Starts Bellicum Pharmaceuticals (BLCM) at Buy
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Price: $0.62 --0%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Ladenburg Thalmann initiated coverage on Bellicum Pharmaceuticals (NASDAQ: BLCM) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Bellicum Pharmaceuticals click here. For more ratings news on Bellicum Pharmaceuticals click here.
Shares of Bellicum Pharmaceuticals closed at $19.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- JPMorgan Starts Lovisa Holdings Ltd (LOV:AU) at Neutral
- UBS Starts Intershop Holding AG (ISN:SW) at Sell
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
